The effects of a new opioid analgesic, meptazinol, on the respiration of the conscious rat

Article date: May 1985

By: I.S. Cowlrick, N.B. Shepperson in Volume 85, Issue 1, pages 205-211

In the conscious rat arterial PCO2 was measured as an index of respiratory status.

The opioid analgesic meptazinol (7.5–30 mg kg−1) evoked small but significant increases in arterial PCO2 which were attenuated by naloxone.

Meptazinol significantly reduced the increase in arterial PCO2 evoked by morphine.

The respiratory depression induced by meptazinol, but not that induced by morphine, was enhanced by pretreatment with atropine.

The (+)‐enantiomer, but not the (‐)‐enantiomer of meptazinol increased arterial PCO2. In contrast, only the (‐)‐enantiomer reduced the respiratory depressant effect of morphine.

It is proposed that the degree of respiratory depression induced by meptazinol is limited by its opioid antagonist and cholinomimetic properties.

In the conscious rat arterial PCO2 was measured as an index of respiratory status.

The opioid analgesic meptazinol (7.5–30 mg kg−1) evoked small but significant increases in arterial PCO2 which were attenuated by naloxone.

Meptazinol significantly reduced the increase in arterial PCO2 evoked by morphine.

The respiratory depression induced by meptazinol, but not that induced by morphine, was enhanced by pretreatment with atropine.

The (+)‐enantiomer, but not the (‐)‐enantiomer of meptazinol increased arterial PCO2. In contrast, only the (‐)‐enantiomer reduced the respiratory depressant effect of morphine.

It is proposed that the degree of respiratory depression induced by meptazinol is limited by its opioid antagonist and cholinomimetic properties.

DOI: 10.1111/j.1476-5381.1985.tb08848.x

View this article